Praxis Precision Medicines Inc at Bank of America Global Healthcare Conference Transcript
(audio in progress) Praxis, who's going to run through a presentation? Megan?
Thank you. Hi, good afternoon. I'm Megan Sniecinski, the Chief Operating Officer at Praxis.
Building on a remarkable 2025, we've continued executing across our portfolio in our journey to become a commercial company. We're gaining momentum across all of our four late-stage assets.
These are our forward-looking statements.
Everything we do at Praxis comes back to one thing: accelerating the delivery of life-altering therapies for patients suffering from CNS disorders, many of whom have been waiting for decades. Looking at our near-term horizon, what's ahead for us this year sets us up well to deliver on this mission.
I want to use our time today to share more about what's happening across each of our programs; what we're excited about; and what lies ahead for the company.
Our broad pipeline has several near-term catalysts. We're heads-down
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
